A prebiotic-enhanced lipid-based nutrient supplement (LNSp) increases Bifidobacterium relative abundance and enhances short-chain fatty acid production in simulated colonic microbiota from undernourished infants

2020 ◽  
Vol 96 (7) ◽  
Author(s):  
Laeticia Celine Toe ◽  
Frederiek-Maarten Kerckhof ◽  
Jana De Bodt ◽  
Fanny B Morel ◽  
Jean-Bosco Ouedraogo ◽  
...  

ABSTRACT Undernutrition remains a public health problem in the developing world with an attributable under-five death proportion of 45%. Lower gut microbiota diversity and poor metabolic output are associated with undernutrition and new therapeutic paths may come from steering gut microbiota composition and functionality. Using a dynamic gut model, the Simulator of Human Intestinal Microbial Ecosystem (SHIME®), we investigated the effect of a lipid-based nutrient supplement enriched with prebiotics (LNSp), compared to LNS alone and control treatment, on the composition and metabolic functionality of fecal microbiota from three infants suffering from undernutrition. LNS elicited a significant increase in acetate and branched-chain fatty acid production, and a higher relative abundance of the genera Prevotella, Megasphaera, Acinetobacter, Acidaminococcus and Pseudomonas. In contrast, LNSp treatment resulted in a significant 9-fold increase in Bifidobacterium relative abundance and a decrease in that of potential pathogens and detrimental bacteria such as Enterobacteriaceae spp. and Bilophila sp. Moreover, the LNSp treatment resulted in a significantly higher production of acetate, butyrate and propionate, as compared to control and LNS. Our results suggest that provision of prebiotic-enhanced LNS to undernourished children could be a possible strategy to steer the microbiota toward a more beneficial composition and metabolic activity. Further in vivo investigations are needed to assess these effects and their repercussion on nutritional status.

2010 ◽  
Vol 50 (7) ◽  
pp. 605-619 ◽  
Author(s):  
S. Millet ◽  
M. J. Van Oeckel ◽  
M. Aluwé ◽  
E. Delezie ◽  
D. L. De Brabander

Nutrients ◽  
2015 ◽  
Vol 7 (11) ◽  
pp. 8916-8929 ◽  
Author(s):  
Eef Boets ◽  
Lise Deroover ◽  
Els Houben ◽  
Karen Vermeulen ◽  
Sara Gomand ◽  
...  

2021 ◽  
Vol 22 (22) ◽  
pp. 12384
Author(s):  
Samuel Connell ◽  
Motoko Kawashima ◽  
Shigeru Nakamura ◽  
Toshihiro Imada ◽  
Hiromitsu Yamamoto ◽  
...  

Lactoferrin is a glycoprotein found at high concentrations within exocrine secretions, including tears. Low levels of lactoferrin have been implicated in the loss of tear secretion and ageing. Furthermore, lactoferrin possesses a range of functionalities, including anti-inflammatory properties and the ability to modulate the gut microbiota. Expanding evidence demonstrates a crucial role of the gut microbiota in immune regulation and development. The specific composition of bacterial species of the gut has a profound influence on local and systemic inflammation, leading to a protective capacity against a number of inflammatory diseases, potentially by the induction of regulatory immune cells. In this study, we demonstrated that oral administration of lactoferrin maintains tear secretion in a restraint and desiccating stress induced mouse model of dry eye disease. Furthermore, we revealed that lactoferrin induces the reduction of inflammatory cytokines, modulates gut microbiota, and induces short-chain fatty acid production. Whereas, the antibiotic vancomycin abrogates the effects of lactoferrin on dry eye disease and significantly reduces short-chain fatty acid concentrations. Therefore, this protective effect of LF against a mice model of DED may be explained by our observations of an altered gut microbiota and an enhanced production of immunomodulatory short-chain fatty acids.


Sign in / Sign up

Export Citation Format

Share Document